An extension of the Benefit Risk Assessment of VaccinEs toolkit to evaluate Comirnaty and Spikevax vaccination in the European Union.

Amid the global COVID-19 pandemic, vaccines were conditionally authorized for human use to protect against severe infection. The Benefit Risk Assessment of VaccinEs (BRAVE) toolkit, a user-friendly R Shiny application, was developed retrospectively together with the European Medicine Agency (EMA) wi...

Descripción completa

Detalles Bibliográficos

Publicado en:	European Journal of Public Health Vol. 35; no. 5; pp. 1007 - 1014
Autores principales:	Loedy, Neilshan, Dorta, Hector G, Abrams, Steven, Crèvecoeur, Jonas, Morales, Daniel R, Cohet, Catherine, Willem, Lander, Molenberghs, Geert, Hens, Niel, Kurz, Xavier, Quinten, Chantal, Verbeeck, Johan
Formato:	equations & formulas research tables/charts Journal Article
Publicado:	Oxford University Press / USA Oct2025
Acceso en línea:	Ver este registro en EBSCOhost